Literature DB >> 25606537

A future in our past: the umbilical cord for orthopaedic tissue engineering.

Antonio Marmotti1, Giuseppe Maria Peretti2, Silvia Mattia3, Davide Edoardo Bonasia1, Matteo Bruzzone1, Federico Dettoni1, Roberto Rossi1, Filippo Castoldi1.   

Abstract

The umbilical cord (UC) has recently been added to the list of potential cell sources for tissue engineering and regenerative medicine purposes. Although the UC is usually discarded after delivery, UC storage in special tissue banks is becoming an increasingly common procedure. Indeed, the capacity of UC cells to be directed toward different phenotypes makes this tissue an ideal cell source for regenerative medicine in orthopedics and in other fields. In this paper, these issues are presented and discussed, together with the potential of this cell source for allogeneic use. This article also looks at the anatomy of the UC from both the macroscopic and the cellular perspective and considers its extraordinary potential for research and clinical applications.

Keywords:  chondrogenic; mesenchymal stem cells; osteogenic; tissue engineering; umbilical cord

Year:  2014        PMID: 25606537      PMCID: PMC4295663     

Source DB:  PubMed          Journal:  Joints        ISSN: 2512-9090


  17 in total

1.  Effective treatment of severe steroid-resistant acute graft-versus-host disease with umbilical cord-derived mesenchymal stem cells.

Authors:  Kang-Hsi Wu; Chin-Kan Chan; Chris Tsai; Yu-Hsiang Chang; Martin Sieber; Tsan-Hung Chiu; Ming Ho; Ching-Tien Peng; Han-Ping Wu; Jing-Long Huang
Journal:  Transplantation       Date:  2011-06-27       Impact factor: 4.939

Review 2.  Stem cells from umbilical cord and placenta for musculoskeletal tissue engineering.

Authors:  Umile Giuseppe Longo; Mattia Loppini; Alessandra Berton; Luca La Verde; Wasim S Khan; Vincenzo Denaro
Journal:  Curr Stem Cell Res Ther       Date:  2012-07       Impact factor: 3.828

3.  The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds.

Authors:  Rebekka K Schneider; Andrea Puellen; Rafael Kramann; Kerstin Raupach; Jörg Bornemann; Ruth Knuechel; Alberto Pérez-Bouza; Sabine Neuss
Journal:  Biomaterials       Date:  2009-10-07       Impact factor: 12.479

4.  Human umbilical cord Wharton's jelly stem cells undergo enhanced chondrogenic differentiation when grown on nanofibrous scaffolds and in a sequential two-stage culture medium environment.

Authors:  Chui-Yee Fong; Arjunan Subramanian; Kalamegam Gauthaman; Jayarama Venugopal; Arijit Biswas; Seeram Ramakrishna; Ariff Bongso
Journal:  Stem Cell Rev Rep       Date:  2012-03       Impact factor: 5.739

Review 5.  Mesenchymal stem cells derived from Wharton's Jelly of the umbilical cord: biological properties and emerging clinical applications.

Authors:  Aristea K Batsali; Maria-Christina Kastrinaki; Helen A Papadaki; Charalampos Pontikoglou
Journal:  Curr Stem Cell Res Ther       Date:  2013-03       Impact factor: 3.828

6.  Injection of human umbilical tissue-derived cells into the nucleus pulposus alters the course of intervertebral disc degeneration in vivo.

Authors:  Steven K Leckie; Gwendolyn A Sowa; Bernard P Bechara; Robert A Hartman; Joao Paulo Coelho; William T Witt; Qing D Dong; Brent W Bowman; Kevin M Bell; Nam V Vo; Brian C Kramer; James D Kang
Journal:  Spine J       Date:  2013-02-04       Impact factor: 4.166

Review 7.  Wharton's jelly-derived cells are a primitive stromal cell population.

Authors:  Deryl L Troyer; Mark L Weiss
Journal:  Stem Cells       Date:  2007-12-06       Impact factor: 6.277

8.  A comparison of human bone marrow-derived mesenchymal stem cells and human umbilical cord-derived mesenchymal stromal cells for cartilage tissue engineering.

Authors:  Limin Wang; Ivy Tran; Kiran Seshareddy; Mark L Weiss; Michael S Detamore
Journal:  Tissue Eng Part A       Date:  2009-08       Impact factor: 3.845

9.  Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.

Authors:  Shuyun Liu; Ke Dong Hou; Mei Yuan; Jiang Peng; Li Zhang; Xiang Sui; Bin Zhao; Wenjing Xu; Aiyuan Wang; Shibi Lu; Quanyi Guo
Journal:  J Biosci Bioeng       Date:  2013-07-27       Impact factor: 2.894

10.  Minced umbilical cord fragments as a source of cells for orthopaedic tissue engineering: an in vitro study.

Authors:  A Marmotti; S Mattia; M Bruzzone; S Buttiglieri; A Risso; D E Bonasia; D Blonna; F Castoldi; R Rossi; C Zanini; E Ercole; E Defabiani; C Tarella; G M Peretti
Journal:  Stem Cells Int       Date:  2012-03-07       Impact factor: 5.443

View more
  5 in total

Review 1.  Regenerative approaches for the treatment of early OA.

Authors:  L de Girolamo; E Kon; G Filardo; A G Marmotti; F Soler; G M Peretti; F Vannini; H Madry; S Chubinskaya
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-04-27       Impact factor: 4.342

Review 2.  Bone marrow derived stem cells in joint and bone diseases: a concise review.

Authors:  Antonio Marmotti; Laura de Girolamo; Davide Edoardo Bonasia; Matteo Bruzzone; Silvia Mattia; Roberto Rossi; Angela Montaruli; Federico Dettoni; Filippo Castoldi; Giuseppe Peretti
Journal:  Int Orthop       Date:  2014-07-09       Impact factor: 3.075

3.  Allogeneic Umbilical Cord-Derived Mesenchymal Stem Cells as a Potential Source for Cartilage and Bone Regeneration: An In Vitro Study.

Authors:  A Marmotti; S Mattia; F Castoldi; A Barbero; L Mangiavini; D E Bonasia; M Bruzzone; F Dettoni; R Scurati; G M Peretti
Journal:  Stem Cells Int       Date:  2017-11-16       Impact factor: 5.443

Review 4.  Cartilage repair in the degenerative ageing knee.

Authors:  Mats Brittberg; Andreas H Gomoll; José A Canseco; Jack Far; Martin Lind; James Hui
Journal:  Acta Orthop       Date:  2016-12-02       Impact factor: 3.717

5.  Pulsed Electromagnetic Fields Improve Tenogenic Commitment of Umbilical Cord-Derived Mesenchymal Stem Cells: A Potential Strategy for Tendon Repair-An In Vitro Study.

Authors:  Antonio Marmotti; Giuseppe Maria Peretti; Silvia Mattia; Laura Mangiavini; Laura de Girolamo; Marco Viganò; Stefania Setti; Davide Edoardo Bonasia; Davide Blonna; Enrico Bellato; Giovanni Ferrero; Filippo Castoldi
Journal:  Stem Cells Int       Date:  2018-07-30       Impact factor: 5.443

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.